Mustang Bio Statistics
Total Valuation
Mustang Bio has a market cap or net worth of $5.12 million. The enterprise value is -$9.11 million.
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Mustang Bio has 4.38 million shares outstanding. The number of shares has increased by 592.16% in one year.
| Current Share Class | 3.53M |
| Shares Outstanding | 4.38M |
| Shares Change (YoY) | +592.16% |
| Shares Change (QoQ) | +182.82% |
| Owned by Insiders (%) | 0.08% |
| Owned by Institutions (%) | 9.82% |
| Float | 3.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.09 |
| P/TBV Ratio | 1.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.34
| Current Ratio | 1.34 |
| Quick Ratio | 1.32 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,515.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -32.10% |
| Return on Invested Capital (ROIC) | -890.76% |
| Return on Capital Employed (ROCE) | -201.52% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.79M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.18% in the last 52 weeks. The beta is 2.24, so Mustang Bio's price volatility has been higher than the market average.
| Beta (5Y) | 2.24 |
| 52-Week Price Change | -84.18% |
| 50-Day Moving Average | 1.24 |
| 200-Day Moving Average | 6.56 |
| Relative Strength Index (RSI) | 40.25 |
| Average Volume (20 Days) | 93,637 |
Short Selling Information
The latest short interest is 97,080, so 2.22% of the outstanding shares have been sold short.
| Short Interest | 97,080 |
| Short Previous Month | 58,835 |
| Short % of Shares Out | 2.22% |
| Short % of Float | 2.92% |
| Short Ratio (days to cover) | 0.65 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.58M |
| Pretax Income | -40.10M |
| Net Income | -10.71M |
| EBITDA | -7.16M |
| EBIT | -7.58M |
| Earnings Per Share (EPS) | -$8.42 |
Full Income StatementBalance Sheet
The company has $14.23 million in cash and n/a in debt, giving a net cash position of $14.23 million or $3.25 per share.
| Cash & Cash Equivalents | 14.23M |
| Total Debt | n/a |
| Net Cash | 14.23M |
| Net Cash Per Share | $3.25 |
| Equity (Book Value) | 3.61M |
| Book Value Per Share | 1.07 |
| Working Capital | 3.76M |
Full Balance SheetCash Flow
| Operating Cash Flow | -7.48M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.48M |
| FCF Per Share | -$1.71 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |